Skip to content

Darren Riddy

  • BSc (Hons), BPS Dip Pharmacol
  • Monash Institute of Pharmaceutical Sciences
  • 5h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 70CitationsNumber of citations received by Darren's publications. Updated daily.

Research interests

Drug developmentPharmacologyType 2 diabetesGPCR

Co-authors (60)

Publications (5)

  • G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus

    • Riddy D
    • Delerive P
    • Summers R
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<inf>2</inf>Receptor Antagonist for Treatment of Asthma

    • Sandham D
    • Barker L
    • Brown L
    • et al.
    N/AReaders
    0Citations
    Get full text
  • Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists

    • Riddy D
    • Cook A
    • Diepenhorst N
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • QAW039, a slowly dissociating CRTh2 antagonist with potential for improved clinical efficacy

    • Sykes D
    • Bradley M
    • Riddy D
    • et al.
    N/AReaders
    N/ACitations
  • Effect of alosetron and tegaserod at the 5-HT2B receptor in human colon

    • Borman R
    • Wade J
    • Root J
    • et al.
    N/AReaders
    N/ACitations

Professional experience

Monash Institute of Pharmaceutical Sciences

Education

PhD

Monash Institute of Pharmaceutical Sciences

October 2014 - Present

Diploma, Advanced Pharmacology

British Medical Association

January 2009 - December 2011(3 years)

BSc (Hons) Applied Biology

University of Hertfordshire

October 1999 - June 2004(5 years)